ROYAL BANK OF CANADA - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 90 filers reported holding CASCADIAN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,000
-88.2%
732
-82.1%
0.00%
Q3 2017$17,000
+466.7%
4,087
+270.2%
0.00%
Q2 2017$3,000
-25.0%
1,104
+9.3%
0.00%
Q1 2017$4,0000.0%1,010
+0.4%
0.00%
Q4 2016$4,0001,0060.00%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Abingworth LLP 925,000$3,783,0002.62%
EcoR1 Capital, LLC 3,000,000$12,270,0001.64%
BVF INC/IL 3,133,224$12,815,0001.63%
Sandia Holdings, LLC 927,264$3,793,0001.63%
NEA Management Company, LLC 9,064,575$37,074,0001.30%
P.A.W. CAPITAL CORP 240,000$982,0001.03%
FT Options LLC 115,206$471,0000.71%
Avoro Capital Advisors LLC 1,821,248$7,449,0000.58%
Baupost Group 8,721,079$35,669,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 681,210$2,786,0000.40%
View complete list of CASCADIAN THERAPEUTICS INC shareholders